During an interview on The Rush Limbaugh Show today, pro-life Vice President Mike Pence said that he hopes and prays Charlie card gets every chance at life.
Charlie suffers from a rare genetic disorder, mitochondrial DNA depletion syndrome, which can cause weakened muscles and organ dysfunction, among other symptoms, and though his parents have raised money for additional treatment and hospitals around the world have volunteered their services, hospital officials have refused to allow the infant to be released to his parents.
As LifeNews reported earlier today, the judge in the case set up another hearing on Thursday to determine whether or not Charlie can receive an experimental treatment to help him with his very rare medical condition. But as one pro-life campaigner tells LifeNews, this was a huge victory for Charlie and his parents.
According to a transcript of the interview, Pence said the following about the infant:
The heartbreaking story of the 11-month-old Charlie Gard in England is a story of single-payer. I know you’ve covered that on this program. And it’s back in court today and frankly we breathe a prayer and the hope that the single-payer system in England will see its way clear to allow the family – the mother and the father – to be able to choose the greatest extent of life-saving treatment that’s available to their child.
SUPPORT PRO-LIFE NEWS! Please help LifeNews.com with a donation
Under single payer people are submitted to a government program that says, “no, we’re going to remove life support from your precious 11-month-old child” because the government has decided that the prospects of their life are such that they no longer warrant an investment in health services.
We hope and pray that little Charlie Gard gets every chance, but the American people ought to reflect on the fact that for all the talk on the left about single-payer, that’s where it takes us.
President Trump has offered to support Charlie’s Family in their attempt to bring him to the United States for an experimental treatment to combat the rare disease he faces.